Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial

Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial

Abstract Background Currently, coronavirus disease-2019 (COVID-19) is continuously and rapidly circulating, resulting in serious and extensive effects on human health. Due to the absence of antiviral medicine for COVID-19 thus far, there is a desperate need to develop effective medicine. Traditional...

Full description

Bibliographic Details
Main Authors: Wen Zhang, Qin Xie, Xiaoming Xu, Shuting Sun, Tian Fan, Xinxin Wu, Yao Qu, Jinhua Che, Tingrong Huang, Huacheng Li, You Zheng, Chao Jiang, Bangjiang Fang, Shuang Zhou
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Trials
Subjects:
COVID-19
Baidu Jieduan granule
Efficacy and safety
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-021-05418-y

Internet

https://doi.org/10.1186/s13063-021-05418-y

Similar Items